Ibuprofen

Treatment for Tension Headache

Typical Dosage: 200-400 mg every 4-6 hours, max 1200 mg/day (OTC)

Effectiveness
68%
Safety Score
75%
Clinical Trials
5
Participants
75K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
75
DangerousModerateSafe
Treatment Details
Dosage Range
200-400 mg every 4-6 hours, max 1200 mg/day (OTC)
Time to Effect
30-60 minutes
Treatment Duration
As needed for acute episodes
Evidence Quality
HIGH
Number Needed to Treat (NNT)
7(Treat 7 patients to see 1 additional successful outcome)
Confidence Score
89%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$30
Monitoring:$1,000
Side Effect Mgmt:$10
Total Annual:$1,040
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0.03
Outcome-Based Costs
Cost per Responder
$61.54
Ibuprofen Outcomes

for Tension Headache

Efficacy Outcomes
Overall Effectiveness
+68%
Response Rate
+65%
Common Side Effects
Dyspepsia
+15%
Nausea
+6%
Abdominal pain
+6%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov

Completed Clinical Trials
3 completed trials for Ibuprofen in Tension Headache

Placebo and Active Controlled, Double Dummy Study to Compare Efficacy of Aspirin and Ibuprofen in Treatment of Episodic Tension-type Headache

NCT01464983COMPLETEDPHASE4
View Study
1.11K participants
INTERVENTIONAL
Reading, United Kingdom +10 more
Started: Jan 1, 2004

Ibuprofen Sodium Tension Headache Study

NCT01362491COMPLETEDPHASE3
View Study
226 participants
INTERVENTIONAL
Philadelphia, United States
Started: Jun 1, 2011

Study Evaluating A Novel Ibuprofen Formulation In Episodic Tension-Type Headache

NCT01077973COMPLETEDPHASE3
View Study
200 participants
INTERVENTIONAL
Started: Mar 1, 2010